Greater Occipital Nerve Block for Migraine With Medication Overuse Headache

NCT ID
NCT07568496
Registry status
Recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Mahidol University
Conditions
Greater Occipital Nerve Block, Medication Overuse Headache, Migraine Disorders

Overview

ClinicalTrials.gov lists this study as Recruiting.

Enrollment: 130 participants (Estimated).

What is being studied

  • Intervention: Acetanilides
  • Intervention: Amides
  • Intervention: Amines
  • Intervention: Anilides
  • Intervention: Aniline Compounds
  • Intervention: Fused-Ring Compounds
  • Intervention: Lidocaine
  • Drug: Lidocaine 2% and Methylprednisolone 80 mg
  • Intervention: Methylprednisolone
  • Intervention: Organic Chemicals
  • Other: Placebo
  • Intervention: Polycyclic Compounds
  • Intervention: Prednisolone
  • Intervention: Pregnadienes
  • Intervention: Pregnadienetriols
  • Intervention: Pregnanes
  • Intervention: Steroids

Who may be eligible

Ages
18 Years to 80 Years
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Patients who have a diagnosis of migraine with medication overuse headache according to ICHD-3 criteria confirmed by a neurologist * Female patients will be screened for pregnancy planning and married female patients must undergo a urine pregnancy test Exclusion Criteria: * Patients who have other types of headache disorders other than migraine * Patients who have a previous history of allergy to corticosteroid or lidocaine * Patients who had previous skull surgery * Pregnant women * Patients with a history of uncontrolled depression, or psychosis * Patients who get or plan to get CGRP-targeted therapies or botulinum toxin injection * Patients with an increased risk of bleeding or underlying bleeding disorders

Study locations

3 study locations are listed.

Recruiting site status is explicitly provided for 3 locations; 2 are listed as Recruiting.

Countries: Thailand

  • Bangkok, Thailand: 1
  • Changwat Songkhla, Thailand: 1
  • Chiang Mai, Thailand: 1

Sample of listed locations

  • Faculty of Medicine Siriraj Hospital, Mahidol University — Bangkok, Bangkok, 10700, Thailand — Recruiting
  • Faculty of Medicine, Prince of Songkla University — Hat Yai, Changwat Songkhla, 90110, Thailand — Recruiting
  • Faculty of Medicine, Chiang Mai University — Chiang Mai, Chiang Mai, 50200, Thailand — Not yet recruiting

Study details

Start date
May 12, 2026
Primary completion date
November 1, 2028
Completion date
November 1, 2028
First posted
May 5, 2026
Collaborators
Chiang Mai University, Thailand, Prince of Songkla University, The Royal College of Physicians of Thailand

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07568496
Registry last updated
October 8, 2026
QualifiedStudies registry data refreshed
October 12, 2026
QualifiedStudies record fetched
October 12, 2026

View NCT07568496 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Migraines studies | Clinical trial FAQ